Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jae Weon Kim

Showing results (181-190 of 404) with videos related to

Pageof 41
Sort By:
Experimental & Molecular Medicine|July 5, 2006
Association between excision repair cross-complementation group 1 polymorphism and clinical outcome of platinum-based chemotherapy in patients with epithelial ovarian cancerSokbom Kang, Woong Ju, Jae Weon Kim, et al.
Gynecologic Oncology|October 25, 2016
Treatment preferences of advanced ovarian cancer patients for adding bevacizumab to first-line therapyJung-Yun Lee, Kyunghoon Kim, Yun Shin Lee, et al.
Journal of Gynecologic Oncology|May 1, 2015
Cost-effectiveness of para-aortic lymphadenectomy before chemoradiotherapy in locally advanced cervical cancerJung Yun Lee, Younhee Kim, Tae Jin Lee, et al.
Annals of Surgical Oncology|December 22, 2016
Treatment Preferences for Routine Lymphadenectomy Versus No Lymphadenectomy in Early-Stage Endometrial CancerJung-Yun Lee, Kyunghoon Kim, Yun Shin Lee, et al.
Journal of Clinical Medicine|November 14, 2019
Real-World Experience of Olaparib Maintenance in High-Grade Serous Recurrent Ovarian Cancer Patients with <i>BRCA1/2</i> Mutation: A Korean Multicenter StudyE Sun Paik, Yong Jae Lee, Jung-Yun Lee, et al.
Journal of Gynecologic Oncology|April 23, 2020
Major clinical research advances in gynecologic cancer in 2019Miseon Kim, Dong Hoon Suh, Kyung Hun Lee, et al.
Journal of Gynecologic Oncology|October 3, 2019
A phase II study of neoadjuvant chemotherapy plus durvalumab and tremelimumab in advanced-stage ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 3046), TRU-DJung Yun Lee, Jae Weon Kim, Myong Cheol Lim, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 6, 2010
Systematic lymphadenectomy for survival in epithelial ovarian cancer: a meta-analysisHee Seung Kim, Woong Ju, Byung Chul Jee, et al.
Medical Hypotheses|June 26, 2009
Inadvertent potential risk of neoadjuvant chemotherapy in cervical cancerKidong Kim, Min-Jeong Kim, Hyun Hoon Chung, et al.
Gynecologic Oncology|December 14, 2017
Genomic landscape of ovarian clear cell carcinoma via whole exome sequencingSe Ik Kim, Ji Won Lee, Maria Lee, et al.
Pageof 41

Showing results (181-190 of 404) with videos related to

Sort By:
Pageof 41
Experimental & Molecular Medicine|July 5, 2006
Association between excision repair cross-complementation group 1 polymorphism and clinical outcome of platinum-based chemotherapy in patients with epithelial ovarian cancerSokbom Kang, Woong Ju, Jae Weon Kim, et al.
Gynecologic Oncology|October 25, 2016
Treatment preferences of advanced ovarian cancer patients for adding bevacizumab to first-line therapyJung-Yun Lee, Kyunghoon Kim, Yun Shin Lee, et al.
Journal of Gynecologic Oncology|May 1, 2015
Cost-effectiveness of para-aortic lymphadenectomy before chemoradiotherapy in locally advanced cervical cancerJung Yun Lee, Younhee Kim, Tae Jin Lee, et al.
Annals of Surgical Oncology|December 22, 2016
Treatment Preferences for Routine Lymphadenectomy Versus No Lymphadenectomy in Early-Stage Endometrial CancerJung-Yun Lee, Kyunghoon Kim, Yun Shin Lee, et al.
Journal of Clinical Medicine|November 14, 2019
Real-World Experience of Olaparib Maintenance in High-Grade Serous Recurrent Ovarian Cancer Patients with <i>BRCA1/2</i> Mutation: A Korean Multicenter StudyE Sun Paik, Yong Jae Lee, Jung-Yun Lee, et al.
Journal of Gynecologic Oncology|April 23, 2020
Major clinical research advances in gynecologic cancer in 2019Miseon Kim, Dong Hoon Suh, Kyung Hun Lee, et al.
Journal of Gynecologic Oncology|October 3, 2019
A phase II study of neoadjuvant chemotherapy plus durvalumab and tremelimumab in advanced-stage ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 3046), TRU-DJung Yun Lee, Jae Weon Kim, Myong Cheol Lim, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 6, 2010
Systematic lymphadenectomy for survival in epithelial ovarian cancer: a meta-analysisHee Seung Kim, Woong Ju, Byung Chul Jee, et al.
Medical Hypotheses|June 26, 2009
Inadvertent potential risk of neoadjuvant chemotherapy in cervical cancerKidong Kim, Min-Jeong Kim, Hyun Hoon Chung, et al.
Gynecologic Oncology|December 14, 2017
Genomic landscape of ovarian clear cell carcinoma via whole exome sequencingSe Ik Kim, Ji Won Lee, Maria Lee, et al.
Pageof 41